Cite

HARVARD Citation

    Lv, Q. et al. (2022). Sequentially immune‐induced antibodies could cross‐neutralize SARS‐CoV‐2 variants. Animal models and experimental medicine. 5 (1), pp. 89-93. [Online]. 
  
Back to record